Disclosure Statement

Disclosure Statement

AMP Abstracts Disclosure of Financial Relationships and Resolution of Conflicts of Interest The Association for Molecular Pathology requires that rea...

135KB Sizes 17 Downloads 66 Views

AMP Abstracts

Disclosure of Financial Relationships and Resolution of Conflicts of Interest The Association for Molecular Pathology requires that readers of abstracts accepted for poster presentation at the Annual Meeting be informed of the authors’ academic and professional affiliations, as well as the existence of any relationships that may bias the presentation or which, if known, could give the perception of bias. Authors were asked to disclose potential conflicts of interest. The disclosures were reviewed by the AMP Program Committee prior to acceptance of the abstract. Relationships include, but are not limited to: 1) stock options or bond holdings in a for-profit corporation or self-directed pension plan; 2) research grants; 3) employment (full or part-time); 4) ownership or partnership; 5) consulting fees or other remuneration; 6) nonremunerative positions of influence such as officer, board member, trustee, or public spokesperson; 7) receipt of royalties; 8) speaker’s bureau; 9) other. For full-time employees of industry or government, the affiliation listed in the abstract will constitute full disclosure. Program Committee Several of the organizers of this educational activity disclosed a relevant financial relationship that, in the context of their presentation could be perceived by some as a real or apparent conflict of interest. The disclosures have been reviewed and conflicts of interest resolved or managed. Organizers that disclosed no relevant financial relationship are also listed.    

Christopher D. Coldren, PathGroup Employment at PathGroup, a commercial reference lab Eric J. Duncavage, Washington University at St. Louis Employment as Medical Director, Cofactor Genomics Amy Leber, Nationwide Children’s Hospital Clinical trial research funding from BioFire Diagnostics. Honorarium from BioFire Diagnostics. Belinda Yen-Lieberman, Cleveland Clinic Member, Roche Diagnostics Advisory Board

The remaining AMP 2017 Program Committee members have no relevant financial relationships to disclose:          

Lynne V. Abruzzo, The Ohio State University Bryan Betz, University of Michigan William Edward Highsmith, Mayo Clinic Linda Jeng, University of Maryland School of Medicine Alexander Craig Mackinnon, Medical College of Wisconsin Cindy A. Meadows, ARUP Laboratories Somak Roy, University of Pittsburgh Medical Center Daniel E. Sabath, University of Washington Lynette M. Sholl, Brigham and Women’s Hospital Lynne H. Whetsell, Saint Francis Hospital

  

Lucia P. Barker, Association for Molecular Pathology Kathleen L. Carmody, Association for Molecular Pathology Sara Hamilton, Association for Molecular Pathology

Authors of Abstracts A list of authors who indicated a relevant financial relationship is posted on the AMP 2017 Annual Meeting Abstracts webpage: http://amp17.amp.org/abstracts-posters/abstract-submission-information/. If an author is not listed, then s/he did not disclose a relationship.

942

The Journal of Molecular Diagnostics ■ jmd.amjpathol.org